STOCK TITAN

[Form 4] Streamline Health Solutions, Inc. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

Benjamin L. Stilwill, who serves as President and CEO and is a director of Streamline Health Solutions (STRM), filed a Form 4 reporting dispositions of common stock on 08/12/2025 tied to a completed merger. Under the Merger Agreement, Merger Sub merged with and into the issuer and the issuer became a wholly owned subsidiary of Mist Holding Co.

At the effective time each outstanding share of common stock was canceled and converted into the right to receive $5.34 in cash per share. The filing also states that 13,712 restricted stock awards were canceled and converted into cash equal to the number of shares times the Merger Consideration, less applicable withholding taxes. The Form 4 notes inclusion of 3 shares owned by a spouse in the reported holdings.

Benjamin L. Stilwill, che ricopre la carica di Presidente e CEO nonché quella di amministratore di Streamline Health Solutions (STRM), ha presentato un Form 4 segnalando la cessione di azioni ordinarie in data 08/12/2025 collegata a una fusione completata. In base all'Accordo di Fusione, Merger Sub si è fusa con e nell'emittente, che è diventato una controllata interamente posseduta da Mist Holding Co.

Al momento dell'efficacia, ciascuna azione ordinaria in circolazione è stata annullata e convertita nel diritto a ricevere $5.34 in contanti per azione. La comunicazione precisa inoltre che sono stati annullati 13,712 restricted stock awards, convertiti in contanti pari al numero di azioni moltiplicato per il corrispettivo di fusione, al netto delle ritenute fiscali applicabili. Il Form 4 segnala inoltre l'inclusione di 3 azioni di proprietà del coniuge tra le partecipazioni dichiarate.

Benjamin L. Stilwill, quien se desempeña como presidente y director ejecutivo y es miembro del consejo de Streamline Health Solutions (STRM), presentó un Formulario 4 informando sobre disposiciones de acciones ordinarias el 08/12/2025 vinculadas a una fusión completada. Conforme al Acuerdo de Fusión, Merger Sub se fusionó con y en el emisor, y este pasó a ser una subsidiaria de propiedad total de Mist Holding Co.

En el momento de la entrada en vigor, cada acción ordinaria en circulación fue cancelada y convertida en el derecho a recibir $5.34 en efectivo por acción. La presentación añade que 13,712 restricted stock awards fueron canceladas y convertidas en efectivo equivalente al número de acciones multiplicado por la consideración de la fusión, menos las retenciones fiscales aplicables. El Formulario 4 también señala la inclusión de 3 acciones pertenecientes al cónyuge en las participaciones reportadas.

Benjamin L. Stilwill는 Streamline Health Solutions(STRM)의 사장 겸 최고경영자이며 이사로서, 완료된 합병과 관련된 보통주 처분을 08/12/2025자 Form 4에 보고했습니다. 합병계약에 따라 Merger Sub는 발행회사와 합병되었고, 발행회사는 Mist Holding Co.의 전액 출자 자회사가 되었습니다.

합병 효력 발생 시 모든 발행 보통주는 취소되어 주당 $5.34의 현금을 받을 권리로 전환되었습니다. 제출서류에는 또한 13,712개의 제한 주식 보상이 취소되어 해당 주식 수에 합병대가를 곱한 금액에서 적용되는 원천징수세를 공제한 만큼 현금으로 전환되었다고 기재되어 있습니다. Form 4에는 신고된 보유내역에 배우자가 소유한 3주가 포함되어 있음을 명시하고 있습니다.

Benjamin L. Stilwill, qui est président-directeur général et administrateur de Streamline Health Solutions (STRM), a déposé un formulaire 4 signalant des cessions d'actions ordinaires le 08/12/2025 liées à une fusion finalisée. En vertu de l'accord de fusion, Merger Sub a fusionné avec et dans l'émetteur, et l'émetteur est devenu une filiale en propriété exclusive de Mist Holding Co.

Au moment de l'entrée en vigueur, chaque action ordinaire en circulation a été annulée et convertie en droit de recevoir $5.34 en espèces par action. Le dépôt indique également que 13,712 restricted stock awards ont été annulées et converties en espèces équivalentes au nombre d'actions multiplié par la contrepartie de la fusion, nettes des retenues fiscales applicables. Le formulaire 4 précise par ailleurs l'inclusion de 3 actions détenues par un conjoint dans les avoirs déclarés.

Benjamin L. Stilwill, der als Präsident und CEO tätig ist und dem Vorstand von Streamline Health Solutions (STRM) angehört, reichte am 08/12/2025 ein Form 4 ein, in dem Veräußerungen von Stammaktien im Zusammenhang mit einer abgeschlossenen Fusion gemeldet werden. Nach der Fusionsvereinbarung fusionierte Merger Sub mit dem Emittenten, und der Emittent wurde eine hundertprozentige Tochtergesellschaft der Mist Holding Co.

Zum Zeitpunkt des Wirksamwerdens wurden alle ausstehenden Stammaktien annulliert und in das Recht auf Erhalt von $5.34 in bar pro Aktie umgewandelt. Die Einreichung gibt ferner an, dass 13,712 Restricted Stock Awards annulliert und in Bargeld umgewandelt wurden, wobei der Betrag sich aus der Anzahl der Aktien multipliziert mit der Fusionsvergütung abzüglich der anwendbaren Quellensteuern ergab. Das Form 4 weist außerdem darauf hin, dass 3 Aktien, die dem Ehepartner gehören, in den gemeldeten Beständen enthalten sind.

Positive
  • Completed merger converted each outstanding common share into $5.34 cash per share
  • 13,712 restricted stock awards were expressly converted into cash consideration under the merger terms
  • Reporting person is the issuer's President and CEO and a director, and the Form 4 ties insider dispositions directly to the Merger Agreement
Negative
  • The issuer survives as a wholly owned subsidiary of the buyer, removing public common stock ownership for prior public shareholders

Insights

TL;DR Completed cash merger at $5.34 per share; insider dispositions reflect a liquidity event for shareholders.

The Form 4 documents a material corporate transaction: all outstanding common shares were canceled and converted into a fixed cash payment of $5.34 per share at the effective time of the merger. For investors, this represents a definitive cash exit for holders of public equity rather than ongoing public ownership. The filing explicitly notes conversion of vested and unvested restricted awards into cash proceeds (13,712 restricted shares), and identifies the reporting person as the issuer's President and CEO, underscoring that senior management participated in the cash-out on the stated terms.

TL;DR The merger closed with share cancellation and cash consideration; the issuer is now a wholly owned subsidiary of the buyer.

The disclosure describes a classic cash-out merger structure: Merger Sub merged into the issuer and, at the effective time, each share of common stock was cancelled for a cash payment of $5.34 per share. The filing confirms treatment of restricted stock awards as cash-equivalent consideration (13,712 awards converted), and notes the issuer now survives as a wholly owned subsidiary of Mist Holding Co. These details are material to capital structure and liquidity outcomes for prior public shareholders.

Benjamin L. Stilwill, che ricopre la carica di Presidente e CEO nonché quella di amministratore di Streamline Health Solutions (STRM), ha presentato un Form 4 segnalando la cessione di azioni ordinarie in data 08/12/2025 collegata a una fusione completata. In base all'Accordo di Fusione, Merger Sub si è fusa con e nell'emittente, che è diventato una controllata interamente posseduta da Mist Holding Co.

Al momento dell'efficacia, ciascuna azione ordinaria in circolazione è stata annullata e convertita nel diritto a ricevere $5.34 in contanti per azione. La comunicazione precisa inoltre che sono stati annullati 13,712 restricted stock awards, convertiti in contanti pari al numero di azioni moltiplicato per il corrispettivo di fusione, al netto delle ritenute fiscali applicabili. Il Form 4 segnala inoltre l'inclusione di 3 azioni di proprietà del coniuge tra le partecipazioni dichiarate.

Benjamin L. Stilwill, quien se desempeña como presidente y director ejecutivo y es miembro del consejo de Streamline Health Solutions (STRM), presentó un Formulario 4 informando sobre disposiciones de acciones ordinarias el 08/12/2025 vinculadas a una fusión completada. Conforme al Acuerdo de Fusión, Merger Sub se fusionó con y en el emisor, y este pasó a ser una subsidiaria de propiedad total de Mist Holding Co.

En el momento de la entrada en vigor, cada acción ordinaria en circulación fue cancelada y convertida en el derecho a recibir $5.34 en efectivo por acción. La presentación añade que 13,712 restricted stock awards fueron canceladas y convertidas en efectivo equivalente al número de acciones multiplicado por la consideración de la fusión, menos las retenciones fiscales aplicables. El Formulario 4 también señala la inclusión de 3 acciones pertenecientes al cónyuge en las participaciones reportadas.

Benjamin L. Stilwill는 Streamline Health Solutions(STRM)의 사장 겸 최고경영자이며 이사로서, 완료된 합병과 관련된 보통주 처분을 08/12/2025자 Form 4에 보고했습니다. 합병계약에 따라 Merger Sub는 발행회사와 합병되었고, 발행회사는 Mist Holding Co.의 전액 출자 자회사가 되었습니다.

합병 효력 발생 시 모든 발행 보통주는 취소되어 주당 $5.34의 현금을 받을 권리로 전환되었습니다. 제출서류에는 또한 13,712개의 제한 주식 보상이 취소되어 해당 주식 수에 합병대가를 곱한 금액에서 적용되는 원천징수세를 공제한 만큼 현금으로 전환되었다고 기재되어 있습니다. Form 4에는 신고된 보유내역에 배우자가 소유한 3주가 포함되어 있음을 명시하고 있습니다.

Benjamin L. Stilwill, qui est président-directeur général et administrateur de Streamline Health Solutions (STRM), a déposé un formulaire 4 signalant des cessions d'actions ordinaires le 08/12/2025 liées à une fusion finalisée. En vertu de l'accord de fusion, Merger Sub a fusionné avec et dans l'émetteur, et l'émetteur est devenu une filiale en propriété exclusive de Mist Holding Co.

Au moment de l'entrée en vigueur, chaque action ordinaire en circulation a été annulée et convertie en droit de recevoir $5.34 en espèces par action. Le dépôt indique également que 13,712 restricted stock awards ont été annulées et converties en espèces équivalentes au nombre d'actions multiplié par la contrepartie de la fusion, nettes des retenues fiscales applicables. Le formulaire 4 précise par ailleurs l'inclusion de 3 actions détenues par un conjoint dans les avoirs déclarés.

Benjamin L. Stilwill, der als Präsident und CEO tätig ist und dem Vorstand von Streamline Health Solutions (STRM) angehört, reichte am 08/12/2025 ein Form 4 ein, in dem Veräußerungen von Stammaktien im Zusammenhang mit einer abgeschlossenen Fusion gemeldet werden. Nach der Fusionsvereinbarung fusionierte Merger Sub mit dem Emittenten, und der Emittent wurde eine hundertprozentige Tochtergesellschaft der Mist Holding Co.

Zum Zeitpunkt des Wirksamwerdens wurden alle ausstehenden Stammaktien annulliert und in das Recht auf Erhalt von $5.34 in bar pro Aktie umgewandelt. Die Einreichung gibt ferner an, dass 13,712 Restricted Stock Awards annulliert und in Bargeld umgewandelt wurden, wobei der Betrag sich aus der Anzahl der Aktien multipliziert mit der Fusionsvergütung abzüglich der anwendbaren Quellensteuern ergab. Das Form 4 weist außerdem darauf hin, dass 3 Aktien, die dem Ehepartner gehören, in den gemeldeten Beständen enthalten sind.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
X
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Stilwill Benjamin Louis

(Last) (First) (Middle)
2400 OLD MILTON PARKWAY
BOX 1353

(Street)
ALPHARETTA GA 30009

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
STREAMLINE HEALTH SOLUTIONS INC. [ STRM ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
X Officer (give title below) Other (specify below)
President and CEO
3. Date of Earliest Transaction (Month/Day/Year)
08/12/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock, $0.01 par value 08/12/2025 D(1) 36,849(2) D (1)(2) 0 D
Common Stock, $0.01 par value 08/12/2025 D(1) 3 D (1) 0 I Includes shares owned by spouse.
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. This Form 4 reports securities disposed pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), dated as of May 29, 2025, by and among the Issuer, Mist Holding Co. ("Parent"), and MD BE Merger Sub, Inc., a wholly owned subsidiary of Parent ("Merger Sub"), pursuant to which Merger Sub merged with and into the Issuer, effective as of August 12, 2025, with the Issuer surviving the Merger as a wholly owned subsidiary of Parent (the "Merger"). Pursuant to the terms of the Merger Agreement, at the effective time of the Merger (the "Effective Time"), each share of common stock, par value $0.01 per share, of the Company ("Common Stock") issued and outstanding as of immediately prior to the Effective Time was canceled and converted into the right to receive $5.34 in cash, without interest (the "Merger Consideration").
2. Includes 13,712 shares of restricted stock. Pursuant to the terms of the Merger Agreement, at the Effective Time, each restricted stock award corresponding to shares of Common Stock that was outstanding and unvested as of immediately prior to the Effective Time was canceled and converted into the right to receive an amount in cash equal to the product of (i) the number of shares of Common Stock corresponding to such award of restricted stock immediately prior to the Effective Time, multiplied by (ii) the Merger Consideration, less applicable withholding taxes.
/s/ Benjamin L. Stilwill 08/14/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Benjamin L. Stilwill report on Form 4 for STRM?

He reported dispositions of common stock pursuant to the Merger Agreement, with the transaction dated 08/12/2025, converting shares into cash consideration.

What was the Merger Consideration per share for STRM?

Each outstanding share of common stock was converted into the right to receive $5.34 in cash per share, without interest.

Were restricted stock awards affected in the STRM merger?

Yes. The filing states 13,712 restricted stock awards were canceled and converted into a cash amount equal to shares times the Merger Consideration, less withholding taxes.

What is the post-merger status of Streamline Health Solutions (STRM)?

The issuer survived the merger as a wholly owned subsidiary of Mist Holding Co.

Does the Form 4 indicate any indirect holdings for the reporting person?

The filing includes an entry of 3 shares that the form notes "includes shares owned by spouse," indicating an indirect holding.
Streamline Health Solutions In

NASDAQ:STRM

STRM Rankings

STRM Latest News

STRM Latest SEC Filings

STRM Stock Data

23.23M
3.60M
17.45%
26.05%
0.51%
Health Information Services
Services-computer Integrated Systems Design
Link
United States
ALPHARETTA